SAVR Versus TAVR: Treating Intermediate-Risk Patients
A patient-centered debate on the safety, efficacy, and durability of transcatheter aortic valve replacement versus surgical aortic valve replacement for intermediate-risk patients.
With Bruce Rutkin, MD; S. Jacob Scheinerman, MD, FACS; and Issam D. Moussa, MD, MBA
